The new plant is expected to become operational in 2009. The facility will be based in Bor, a city located near the fourth largest city in Russia, Nizhny Novgorod.
“This move is of great strategic importance to our pharma business, it will strengthen the company’s leading position and allow for pharmaceutical customers based in the Commonwealth of Independent States to be served more effectively,” says Prof. Dr.-Ing. Udo Ungeheuer, Chairman of the Board of Management of SCHOTT AG.
With respect to pharmaceutical vials and ampoules, the premium quality segment is currently experiencing strong double-digit growth, therefore SCHOTT has decided to support the further market development by building a production site in Russia. SCHOTT has been active in the Russian market for parenteral primary pharmaceutical packaging for years by serving this region in particular from an existing plant in Hungary.
During phase 1, SCHOTT will begin manufacturing primary pharmaceutical packaging with approximately 150 employees. In a mid-term view, a capacity of approximately 300 million units will be installed. The support of regional and local government officials has been playing an important role in the location decision. The chosen property can accommodate further expansion options to meet increased demand.
The pharmaceutical packaging manufacturing plant will become the second production site run by SCHOTT in Russia. The SCHOTT joint venture “SCHOTT Flat Glass Russia” began processing flat glass for ovens and refrigerators at the end of September.